Asthma exacerbations: Putting a lid on the volcano

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 4, 2008, Pages 697-699

  Szefler, Stanley J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Asthma; asthma control; asthma exacerbations; asthma impairment; asthma risk

Indexed keywords

ASTHMA; DISEASE EXACERBATION; EDITORIAL; HUMAN; IMMUNE RESPONSE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RHINOVIRUS; RISK FACTOR;

ALLERGENS; ASTHMA; HUMANS; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS;

EID: 53049099046     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.08.022     Document Type: Editorial

References (14)

1. National Institutes of Health. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. August 2007. NIH publication no. 07-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed September 6, 2008.
2. Expert Panel Report 3 (EPR-3). guidelines for the diagnosis and management of asthma: summary report 2007. J Allergy Clin Immunol 120 (2007) S94-S138
3. Busse W.W., and Lemanske R.F. Expert Panel Report 3: moving forward to improve asthma care. J Allergy Clin Immunol 120 (2007) 1012-1014
4. Szefler S.J., Mitchell H., Sorkness C.A., Gergen P.J., O'Connor G.T., Morgan W.J., et al. Adding exhaled nitric oxide to guideline-based asthma treatment in inner-city adolescents and young adults: a randomized controlled trial. Lancet 372 (2008) 919-926
5. Sears M.R. Epidemiology of asthma exacerbations. J Allergy Clin Immunol 122 (2008) 662-668
6. Sykes A., and Johnston S.J. Etiology of asthma exacerbations. J Allergy Clin Immunol 122 (2008) 685-688
7. Kelly J.T., and Busse W.W. Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol 122 (2008) 671-682
8. Sorkness R.L., Gonzalez-Fernandez G., Bilmeyer E.E., Evans M.D., Gern J.E., and Jarjour N.N. The asthma index: a continuous variable to characterize exacerbations of asthma. J Allergy Clin Immunol 122 (2008) 838-840
9. Covar R.A., Szefler S.J., Zeiger R.S., Sorkness C.A., Moss M., Mauger D.T., et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol 122 (2008) 741-747
10. Sorkness C.A., Lemanske Jr. R.F., Mauger D.T., Boehmer S.J., Chinchilli V.M., Martinez F.D., et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 119 (2007) 64-72
11. Ono E., Mita H., Taniguchi M., Higashi N., Tsuburai T., Hasegawa M., et al. Increase in inflammatory mediator concentrations in exhaled breath condensate after allergen challenge. J Allergy Clin Immunol 122 (2008) 768-773
12. Tantisira K., Silverman E., Mariani T., Xu J., Richter B., Klanderman B., et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 120 (2007) 1285-1291
13. Wenzel S.E., Balzar S., Ampleford E., Hawkins G.A., Busse W.W., Calhoun W.J., et al. IL4Ra mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med 175 (2007) 570-576
14. Lehtinen P., Ruohola A., Vanto T., Vuorinen T., Ruuskanen O., and Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 119 (2007) 570-575